======= TCF7L2 ======= == Gene Information == * **Official Symbol**: TCF7L2 * **Official Name**: transcription factor 7 like 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6934|6934]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQB0|Q9NQB0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TCF7L2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TCF7L2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602228|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]. * **UniProt Summary**: N/A |CTNNB1 binding| |HMG box| |canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition| |regulation of heparan sulfate proteoglycan biosynthetic process| |beta-catenin-TCF7L2 complex| |positive regulation of proteoglycan biosynthetic process| |positive regulation of heparan sulfate proteoglycan biosynthetic process| |myoblast fate commitment| |negative regulation of type B pancreatic cell apoptotic process| |maintenance of DNA repeat elements| |regulation of type B pancreatic cell apoptotic process| |armadillo repeat domain binding| |gamma-catenin binding| |positive regulation of glycoprotein biosynthetic process| |positive regulation of protein export from nucleus| |positive regulation of glycoprotein metabolic process| |nuclear hormone receptor binding| |beta-catenin-TCF complex assembly| |RNA polymerase II repressing transcription factor binding| |myoblast differentiation| |Wnt signaling pathway, calcium modulating pathway| |regulation of protein export from nucleus| |regulation of hormone metabolic process| |regulation of glycoprotein biosynthetic process| |negative regulation of epithelial cell apoptotic process| |protein-DNA complex| |regulation of glycoprotein metabolic process| |positive regulation of epithelial to mesenchymal transition| |positive regulation of nucleocytoplasmic transport| |positive regulation of insulin secretion| |pancreas development| |regulation of epithelial cell apoptotic process| |beta-catenin binding| |regulation of epithelial to mesenchymal transition| |canonical Wnt signaling pathway| |positive regulation of protein binding| |positive regulation of peptide hormone secretion| |PML body| |negative regulation of extrinsic apoptotic signaling pathway| |fat cell differentiation| |regulation of nucleocytoplasmic transport| |positive regulation of hormone secretion| |regulation of smooth muscle cell proliferation| |non-canonical Wnt signaling pathway| |response to glucose| |response to hexose| |cell cycle arrest| |response to monosaccharide| |positive regulation of intracellular protein transport| |regulation of extrinsic apoptotic signaling pathway| |negative regulation of DNA-binding transcription factor activity| |positive regulation of protein kinase B signaling| |response to carbohydrate| |negative regulation of canonical Wnt signaling pathway| |positive regulation of binding| |regulation of insulin secretion| |glucose homeostasis| |carbohydrate homeostasis| |positive regulation of epithelial cell proliferation| |transcription factor complex| |positive regulation of intracellular transport| |regulation of peptide hormone secretion| |negative regulation of Wnt signaling pathway| |transcription regulatory region DNA binding| |regulation of protein binding| |regulation of protein kinase B signaling| |negative regulation of apoptotic signaling pathway| |regulation of intracellular protein transport| |nuclear chromatin| |cell fate commitment| |regulation of hormone secretion| |positive regulation of protein secretion| |regulation of canonical Wnt signaling pathway| |positive regulation of peptide secretion| |positive regulation of cellular protein localization| |transcription factor binding| |regulation of epithelial cell proliferation| |regulation of intracellular transport| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |regulation of binding| |chromatin binding| |regulation of apoptotic signaling pathway| |positive regulation of secretion by cell| |sequence-specific DNA binding| |positive regulation of protein transport| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of DNA-binding transcription factor activity| |positive regulation of secretion| |positive regulation of establishment of protein localization| |protein kinase binding| |regulation of protein secretion| |muscle structure development| |blood vessel development| |regulation of peptide secretion| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |regulation of hormone levels| |regulation of cellular protein localization| |negative regulation of cell cycle| |DNA-binding transcription factor activity| |regulation of protein transport| |regulation of peptide transport| |DNA metabolic process| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |regulation of cellular localization| |positive regulation of cell population proliferation| |positive regulation of cell differentiation| |positive regulation of transport| |negative regulation of cell death| |cell cycle process| |positive regulation of intracellular signal transduction| |regulation of protein localization| |chromosome organization| |chemical homeostasis| |cell-cell signaling| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |protein-containing complex assembly| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|1.72| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.84| |[[:results:exp239|PFI-2 4μM R05 exp239]]|2.17| |[[:results:exp292|Menadione 5μM R06 exp292]]|2.36| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.514| Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7988 * **Expression level (log2 read counts)**: 3.45 {{:chemogenomics:nalm6 dist.png?nolink |}}